Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/60690
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Angelis, Roberta De | - |
dc.contributor.author | Minicozzi, Pamela | - |
dc.contributor.author | Sant, Milena | - |
dc.contributor.author | Dal Maso, Luigino | - |
dc.contributor.author | Brewster, David H. | - |
dc.contributor.author | Osca-Gelis, Gemma | - |
dc.contributor.author | Visser, Otto | - |
dc.contributor.author | Maynadie, Marc | - |
dc.contributor.author | Marcos-Gragera, Rafael | - |
dc.contributor.author | Troussard, Xavier | - |
dc.contributor.author | Agius, Dominic | - |
dc.contributor.author | Roazzi, Paolo | - |
dc.contributor.author | Meneghini, Elisabetta | - |
dc.contributor.author | Monnereau, Alain | - |
dc.contributor.author | Calleja, Neville | - |
dc.date.accessioned | 2020-09-23T09:07:42Z | - |
dc.date.available | 2020-09-23T09:07:42Z | - |
dc.date.issued | 2015 | - |
dc.identifier.citation | De Angelis, R., Minicozzi, P., Sant, M., Dal Maso, L., Brewster, D. H., Osca-Gelis, G.,…Calleja, N. (2015). Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000–2007 : results of EUROCARE-5 population-based study. European Journal of Cancer, 51(15), 2254-2268. | en_GB |
dc.identifier.uri | https://www.um.edu.mt/library/oar/handle/123456789/60690 | - |
dc.description.abstract | Background: Significant advances in the management of patients with lymphoid and myeloid malignancies entered clinical practice in the early 2000’s. The EUROCARE-5 study database provides an opportunity to assess the impact of these changes at the population level by country in Europe. We provide survival estimates for clinically relevant haematological malignancies (HM), using the International Classification of Diseases for Oncology 3, by country, gender and age in Europe. Methods: We estimated age-standardised relative survival using the complete cohort approach for 625,000 adult patients diagnosed in 2000–2007 and followed up to 2008. Survival information was provided by 89 participating cancer registries from 29 European countries. Mean survival in Europe was calculated as the population weighted average of country-specific estimates. Results: On average in Europe, 5-year relative survival was highest for Hodgkin lymphoma (81%; 40,625 cases), poorest for acute myeloid leukaemia (17%; 57,026 cases), and intermediate for non-Hodgkin lymphoma (59%; 329,204 cases), chronic myeloid leukaemia (53%; 17,713 cases) and plasma cell neoplasms (39%; 94,024 cases). Survival was generally lower in Eastern Europe and highest in Central and Northern Europe. Wider between country differences (>10%) were observed for malignancies that benefited from therapeutic advances, such as chronic myeloid leukaemia, chronic lymphocytic leukaemia, follicular lymphoma, diffuse large B-cell lymphoma and multiple myeloma. Lower differences (<10%) were observed for Hodgkin lymphoma. Conclusions: Delayed or reduced access to innovative and appropriate therapies could plausibly have contributed to the observed geographical disparities between European regions and countries. Population based survival by morphological sub-type is important for measuring outcomes of HM management. To better inform quality of care research, the collection of detailed clinical information at the population level should be prioritised. | en_GB |
dc.language.iso | en | en_GB |
dc.publisher | Elsevier Ltd. | en_GB |
dc.rights | info:eu-repo/semantics/restrictedAccess | en_GB |
dc.subject | Lymphomas | en_GB |
dc.subject | Myelodysplastic syndromes | en_GB |
dc.subject | Health surveys -- Europe | en_GB |
dc.subject | Acute myeloid leukemia | en_GB |
dc.subject | Long-term care of the sick -- Europe | en_GB |
dc.subject | Hodgkin's disease | en_GB |
dc.subject | Leukemia | en_GB |
dc.subject | Multiple myeloma | en_GB |
dc.title | Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007 : results of EUROCARE-5 population-based study | en_GB |
dc.type | article | en_GB |
dc.rights.holder | The copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder. | en_GB |
dc.description.reviewed | peer-reviewed | en_GB |
dc.identifier.doi | 10.1016/j.ejca.2015.08.003 | - |
dc.publication.title | European Journal of Cancer | en_GB |
Appears in Collections: | Scholarly Works - FacBenCBH Scholarly Works - FacM&SPH |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Survival_variations_by_country_and_age_for_lymphoid_and_myeloid_malignancies_in_Europe_2000–2007_results_of_EUROCARE-5_population-based_study_2015.pdf Restricted Access | 5.26 MB | Adobe PDF | View/Open Request a copy |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.